If a pharmacogenomic test result can significantly impact on a treatment decision, either to contraindicate usage of a drug or biologic agent or adjust dosing, product labeling should be modified ...

Pharmacogenomic tests will avoid exposing vulnerable patients to drugs that won’t suit them, he explains, without upgrading entire populations to newer, more expensive options. In addition ...

Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine. Hundreds of clinical pharmacogenomics (PGx) tests are currently ...

Gene-driven therapies dominate therapeutic strategies, propelled by cutting-edge sequencing platforms and unique biomarker ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

While Myriad continues to engage with UNH, the company reaffirms this estimate. The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for more than 60 ...

1 Approaching 3 million tests to-date, the strong demand for GeneSight, a category-leading pharmacogenomic test for more than 60 medications commonly prescribed for depression, anxiety, ADHD, and ...

The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for more than 60 medications commonly prescribed for depression, anxiety, ADHD, and other ...